Gilead Sciences (Australia)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (Australia), Australia, covering academic research published from 2002 to 2025. Read More.
Open Access Percentage
61%
Total
Publications
304
Total Open
Publications
186
Total
Citations
5.3K
Open Access
Percentage
61%
Total
Publications
304
Total Open
Publications
186
Total
Citations
5.3K
Breakdown
Publisher Open
27%
Both
26%
Other Platform Open
8%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
60
Hybrid 24%
38
No Guarantees 38%
59
Other Platform Open
Domain 70%
72
Institution 46%
47
Other Internet 11%
11
Preprint 7%
7
Public 6%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 75 |
doaj.org OAI-PMH Repository | Institution | 30 |
Unknown Repository | Other Internet | 6 |
Figshare | Public | 6 |
DOI | Other Internet | 6 |
California Digital Library | Institution | 4 |
University of Bristol | Institution | 3 |
medRxiv | Preprint | 3 |
Europe PMC | Domain | 3 |
cas.cz OAI-PMH Repository | Institution | 3 |